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Fibroblast migration from the peri-wound collagenous stroma into the ﬁbrin-laden wound is critical for granulation
tissue formation and subsequent healing. Previously we found that ﬁbroblast transmigration from a collagen matrix
into a ﬁbrin matrix required ﬁbronectin (FN). Integrins a4b1, a5b1, and avb3 and dermatan sulfate CD44 were
required for this invasive migration. Here we demonstrated that syndecan-4, a transmembrane heparan sulfate (HS)
proteoglycan, known to bind FN, is also required for ﬁbroblast invasive migration of a ﬁbrin/FN gel. This conclusion
was based on ﬁbroblast migration using two independent means of disrupting syndecan-4: heparinase degradation
of HS glycosaminoglycans or suppression of syndecan-4 core protein with antisense oligodeoxynucleotides. Iso-
lated syndecan-4 from these ﬁbroblasts bound Hep II recombinant constructs FN III12-V154FN III12-154FN III12-14
but did not bind the IIICS (V) domain. Furthermore, platelet-derived growth factor (PDGF), which is required to
stimulate ﬁbroblast migration, markedly increased cell levels of syndecan-4 core protein in a time and concen-
tration-dependent fashion. PDGF also induced upregulation of syndecan-4 at transcriptional level as determined by
RT-PCR. These results demonstrate that syndecan-4 is essential for ﬁbroblast invasive migration into ﬁbrin clot
and that PDGF, the stimulus for migration, induces increased syndecan-4 core protein expression.
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After tissue injury, fibroblasts near the wound become ac-
tivated (McClain et al, 1996). As part of the granulation tis-
sue response to injury, fibroblasts transmigrate from the
collagen-rich connective tissue into the wound provisional
matrix, composed mainly of fibrin and fibronectin (FN)
(Clark, 1996). In this provisional matrix, fibrin forms a three-
dimensional (3-D) scaffold while FN provides a conduit for
fibroblast migration (Greiling and Clark, 1997). The migra-
tion is critical for granulation tissue formation and subse-
quent healing. The process requires highly regulated
interactions of tissue cells with the extracellular matrix
(ECM) and growth factors of the wound. The necessity of
FN and three integrin receptors for fibroblast movement
across a collagen/fibrin matrix boundary was demonstrated
using an in vitro model of cell movement in a discontinuous
3-D tissue construct that simulates early wound repair
(Greiling and Clark, 1997; Clark et al, 2003).
Cells interact with FN in part through heterodimeric
transmembrane integrin receptors (Yamada et al, 1996;
Danen and Yamada, 2001). When ligated, these receptors
transmit intercellular signals (Giancotti and Ruoslahti, 1999)
and physically connect to the cytoskeleton (Gumbiner,
1996). Thus, it is not surprising they have been implicated
in cell movement on 2-D surfaces (Huttenlocher et al, 1996)
and in 3-D gels (Greiling and Clark, 1997; Clark et al, 2003)
and surface fibrillar networks (Cukierman et al, 2002).
Proteoglycans (PG) compose another group of trans-
membrane molecules that interact with ECM. These trans-
membrane PG include CD44 (Borland et al, 1998) and the
syndecans (Couchman et al, 2001). CD44 is an alternatively
spliced transmembrane protein which is variably glycated
with galactosaminoglycans (Borland et al, 1998). Recently
we have found that a novel dermatan sulfate (DS) CD44 PG
is critical for human adult dermal fibroblast migration in 3-D
gels of fibrin and FN (Clark et al, 2004). In this paper we
address whether PG from the syndecan family are also re-
quired for such migration.
The syndecan family is composed of four PG in mam-
mals, which are usually glycanated with heparan sulfate
(HS) in an extracellular domain (Bernfield et al, 1992; Yo-
neda and Couchman, 2003). Three of the syndecans are
Abbreviations: BSA, bovine serum albumin; CSPG, chondroitin
sulfate proteoglycan; 3-D, three-dimensional; DMEM, Dulbecco’s
modified Eagle’s medium; DOTAP, N-[1-(2,3-dioleoyloxy)propyl]-
N,N-trimethylammonium methylsulfate; DRB, 5,6-dichloro-
benzimidazole 1-b-ribofuranoside; DS, dermatan sulfate; ECM,
extracellular matrix; EDTA, ethylenediaminetetraacetic acid; FA,
focal adhesions; FBS, fetal bovine serum; FCM, flow cytometry
medium; FITC, fluorescein isothiocyanate; FN, fibronectin; GAG,
glycosaminoglycan; HBSS, Hank’s balanced salt solution; HS, he-
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globulin G; LDH, lactate dehydrogenase; MESF, molecules of
equivalent soluble fluorophore; MTT, methyl thiazole teazolium;
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developmentally regulated with tissue specific distribution.
Syndecan-4 is unusual in that it is normally a minor but
ubiquitous receptor in most cells (Oh and Couchman, 2004).
Importantly, syndecan-4 can be specifically localized in
highly organized cell–matrix junctions, termed focal adhe-
sions (FA), together with integrins (Yoneda and Couchman,
2003). The HS of syndecan-4 can interact with ECM
proteins, such as FN, and modulate integrin signaling
(Couchman and Woods, 1999; Saoncella et al, 1999). The
cytoplasmic domain of syndecan-4 can both bind to and
potentiate the phospholipid-mediated activity of PKCa (Oh
et al, 1998), which itself can be a FA component (Oh et al,
1997). FA are multicomponent signal complexes in which
syndecan-4 can collaborate with integrins in activating in-
tracellular signaling pathways, which modulate cell behavior
such as adhesion and migration (Yoneda and Couchman,
2003). Indeed, CHO-K1 cells overexpressing full-length
syndecan-4 core protein exhibited increased FA formation
and decreased cell motility. On the other hand, cells ex-
pressing syndecan-4 core protein either with a partial or
complete deletion of the cytoplasmic domain or in con-
junction with of an antisense construct demonstrated de-
creased spreading, FA formation, and motility (Longley et al,
1999). Clearly, cell migration requires a balance of synde-
can-4 expression and FA formation.
The importance of syndecan-4 in tissue injury and wound
healing are implicated in several findings. It has been found
that syndecan-4 is induced by a proline-rich antimicrobial
peptide, PR-39, which is present early porcine wound fluid
(Gallo et al, 1994). The peptide selectively induces cultured
murine endothelial and fibroblastic cells to increase tran-
script abundance and cell surface expression of syndecan-
1 and -4. Furthermore, syndecan-4 was induced in the de-
rmis after incisional injury of murine or neonatal human skin
(Gallo et al, 1996). Most importantly, mice lacking synde-
can-4 exhibit delayed wound repair and impaired angio-
genesis (Echtermeyer et al, 2001).
Here we used a 3-D migration assay that simulates early
dermal wound repair to demonstrate that human adult der-
mal fibroblasts require syndecan-4 to invade fibrin/FN clots
from an adjacent collagen matrix. Furthermore, we demon-
strate that syndecan-4 binds the FN type III repeats that
comprise the heparin II binding domain but not the IIICS
domain. In addition, platelet-derived growth factor (PDGF),
a well-known growth and chemotactic factor for fibroblasts
in vitro and a critical factor for healing in vivo (Heldin and
Westermark, 1996), robustly upregulates the expression of
syndecan-4 in fibroblasts at both the translational and tran-
scriptional level.
Results
Fibroblast migration in 3-D gel requires heparin sul-
fate Previous studies demonstrated that FN plays a critical
role in fibroblast invasive migration into a 3-D fibrin gel
(Greiling and Clark, 1997). FN contains multiple cell binding
domains including the RGD-containing domain and the He-
pII domain, which bind cell surface integrin and PG recep-
tors, respectively (McCarthy et al, 1996; Yamada et al,
1996). Interaction of the RGD domain on FN with integrins is
required for 3-D migration of fibroblasts in this system
(Greiling and Clark, 1997). To investigate the role of HS PG
on 3-D migration of human adult dermal fibroblasts, we ex-
posed cells to heparinase I or III, which digests more highly
or less highly sulfated region of HS, respectively.
In the presence of heparinase I or III, fibroblast transmi-
gration was inhibited 88% and 98% of control, respectively
(Fig 1). The lack of migration in the presence of heparinase I
or III was not because of contaminating proteases since ad-
dition of ovomucoid (10 mg per mL), a broad spectrum pro-
tease inhibitor, did not substantial alter the results (data not
shown). Heparinase treatments were not cytotoxic under the
conditions used as determined by lactate dehydrogenase
(LDH) release and methyl thiazole teazolium (MTT) metabolic
assays (data not shown). These results suggest that HS is
essential for fibroblast transmigration in 3-D gel.
Fibroblast syndecan-4 binds to the HepII domain of
FN Syndecan-4, a transmembrane HS PG, can bind FN at
highly cationic Hep II domain and regulate cell migration
(Longley et al, 1999; Yoneda and Couchman, 2003). To de-
termine whether human fibroblast syndecan-4 had differ-
entially binding affinity for different Hep II domain arrays, we
constructed and expressed FNIII12-14, FNIII12-15, and
FNIII12-V15 (Fig 2A). In addition recombinant IIICS (V) was
expressed as it is variably spliced into the FN sequence
between FNIII14 and FNIII15. Cellular 35S-labeled-synde-
can-4 was purified from fibroblasts by antibody affinity
beads and its binding activity to FN fragments determined.
The results showed that syndecan-4 binds FNIII12-
V154FNIII12-154FNIII12-14, but not the IIICS domain
alone (Fig 2B). Similar data were obtained when 35S-labe-
led-whole cell lysates were used for affinity binding rather
than purified syndecan-4 (data not shown). Although the
data failed to show statistical significance of syndecan-4
binding among the three HepII recombinant proteins by
ANOVA, results were reproducible by the two different
assays.
PDGF upregulates the expression of syndecan-4 in ﬁb-
roblast cells The affect of PDGF on syndecan-4 expres-
Figure1
Fibroblast three-dimensional migration requires heparan sulfate.
Collagen gels containing human adult dermal fibroblasts were treated
with or without heparinase I or III. Fibroblast invasive migration from
collagen lattices into fibrin gels was visually counted under phase mi-
croscopy. The data shown are the mean  SD of three determinations
of one experiment and are representative of three different experiments.
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sion in human adult dermal fibroblasts was investigated by
western blot and antibody affinity bead binding. After he-
parinase treatment syndecan-4 was detected at about 54
kDa (Fig 3A), consistent with core protein dimer (Woods
et al, 2000). Results from 35SO4 labeling combined with an-
tibody affinity bead purification indicated that syndecan-4
PG appeared as a smear with the molecular weight mainly
at 180 kDa (data not shown). PDGF treatment induced a
rapid increase of syndecan-4 core protein. Expression
reached a maximal level after 8 h, about a 5-fold increase
from control level (Fig 3A). The induction of syndecan-4 ex-
pression by PDGF also showed a concentration-dependent
response, reaching maximal level at about 30 ng per mL
after an 8 h treatment (Fig 3B). PDGF-induced syndecan-4
expression was also confirmed by using antibody affinity
bead purification (data not shown).
PDGF increases the abundance of syndecan-4
mRNA PDGF-induced increase of syndecan-4 expression
might occur at transcriptional level as reported for integrins
(Gailit et al, 1996; Xu and Clark, 1996). To reveal the role of
PDGF on syndecan-4 transcription, we used RT-PCR to
determine the relative level of syndecan-4 mRNA in fibro-
blasts treated with or without PDGF combined with the use
of a transcriptional inhibitor 5, 6 dichlorobenzimidazole 1-b-
ribofuranoside (DRB). The results showed that syndecan-4
mRNA is present in fibroblast cells (Fig 4). PDGF treatment
induced a 3-fold increase of syndecan-4 mRNA within 24 h
(Fig 4). PDGF-induced increase of syndecan-4 mRNA was
Figure 2
Human fibroblast syndecan-4 binds to the Hep II domain of fibronectin (FN). (A) Diagrammatic representation of FN molecular domain structure.
(B) 35SO4-labeled syndecan-4 binding to FN functional domains, which had been conjugated to agarose beads. The data shown are mean  SD of
three determinations in this experiment and is representative of three different experiments.
Figure 3
Platelet-derived growth factor (PDGF)-induced increase of synde-
can-4 protein in fibroblasts. Human adult dermal fibroblasts were
treated with PDGF (100 ng per mL) for periods up to 24 h (A) or treated
with varying dose of PDGF up to 100 ng per mL for period of 8 h (B).
After treatment with 0.2 U per mL heparinase I and III for 2 h at 371C,
whole cell lysates were subjected to SDS-polyacrylamide gel elect-
rophoresis at 20 mg protein/track, transferred to nitrocellulose, and
probed with an antibody specific for syndecan-4. The proteins were
made visible by the chemiluminescence method. Gels were reprobed
with goat antibody specific for human actin to confirm equal loading.
The data presented are representative of three separate determinations
performed with separate cell lysates.
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strongly inhibited by transcriptional inhibitor DRB. At a con-
centration of 5 mM, DRB completely diminishes the effect of
PDGF (Fig 4). At higher concentration, DRB shows more
inhibition on syndecan-4 mRNA level. When the concentra-
tion of DRB is over 50 mM, the syndecan-4 mRNA is much
lower compared with untreated cells, even in the presence
of PDGF (Fig 4). These results indicate that transmembrane
HS PG, syndecan-4, is regulated by PDGF at the transcrip-
tional level.
Suppression of syndecan-4 expression inhibits ﬁbro-
blast invasive migration into ﬁbrin/FN gels Treatment
with antisense oligodeoxynucleotides against syndecan-4
suppressed the expression of syndecan-4 by 490% in the
presence or absence of 100 ng per mL of PDGF (Fig 5A).
Oligodeoxynucleotides with same base composition as that
of antisense but in a scrambled order showed no significant
effect on syndecan-4 expression. Expression of syndecan-2
(Fig 5B) and integrins (Table I) were not changed in fibro-
blasts treated with syndecan-4 antisense as determined by
immunoblot or quantitative flow cytometry, respectively. In
syndecan-4-antisense treated cells, PDGF-stimulated fib-
roblast migration was abrogated by about 90% (Fig 5C).
Missense oligodeoxynucleotides showed little inhibition on
fibroblast transmigration. Nether antisense, nor scrambled
antisense oligodeoxynucleotides, nor the carrier N-[1-(2,3-
dioleoyloxy) propyl]-N,N-trimethylammonium methyl sulfate
(DOTAP) showed an effect on LDH release or the MTT as-
says (data not shown). Thus, our results were not secondary
to cytotoxic effects of syndecan-4 antisense.
To determine whether bulk reduction in cell surface HS
was responsible for the effect observed by syndecan-4 an-
tisense, we treated cells with syndecan-2 antisense (Fig
6A). No reduction in cell migration was observed (Fig 6B).
Together the results shown in Figs 5 and 6 and Table I
strongly support the hypothesis that syndecan-4 is essential
for PDGF-induced fibroblast transmigration from collagen
gels into fibrin/FN gels.
Discussion
Results presented in this study clearly demonstrated that
the PG syndecan-4 is essential for fibroblast invasive mi-
gration from collagen lattices into fibrin/FN gels. Further-
more, the expression of syndecan-4 is upregulated by
PDGF, the stimulus for cell migration. The demonstration of
the involvement of syndecan-4 in fibroblast migration in 3-D
ECM is in concert with the appearance and function of
syndecan-4 in cutaneous wounds (Gallo et al, 1996; Ech-
termeyer et al, 2001).
FN has binding sites for both integrins and
glycosaminoglycans (GAG) (Clark et al, 2003). It has been
demonstrated that HS chains from glypican and syndecans
bind the HepII domain of FN (Tumova et al, 2000). Interest-
ingly, GAG-binding sites are often expressed in close prox-
imity to integrin-binding domains within ECM molecules
suggesting that cellular recognition of the ECM might in-
Figure5
Syndecan-4 antisense oligodeoxyribonucleotides inhibit the trans-
migration of fibroblasts. Human adult dermal fibroblasts were treated
with or without syndecan-4 (AS) or its scrambled antisense (SAS)
oligodeoxyribonucleotides for 48 h in the presence or absence of 100
ng per mL platelet-derived growth factor (PDGF). At the conclusion of
incubation cells were dissolved in affinity bead binding buffer. After
centrifugation, the supernatants were incubated with affinity agarose
beads to which syndecan antibodies had been conjugated. Bound
syndecans were subjected to SDS-polyacrylamide gel electrophoresis,
transferred to nitrocellulose, and probed with goat antibodies specific
for human syndecan-4 (A) or human syndecan-2 (B). Gels were re-
probed with goat antibodies specific for human actin to confirm equal
loading. The proteins were made visible by the chemiluminescence
method. The data presented are representative of three separate de-
terminations performed with separate cell lysates. (C) Cells were treat-
ed with or without AS or SAS oligodeoxyribonucleotides for 48 h were
subjected to 100 ng per mL PDGF in the transmigration assay (see
Materials and methods). All data presented are means  SD from three
determinations of one experiment and representative of three exper-
iments performed with cells from different antisense treatments.
Figure 4
Platelet-derived growth factor (PDGF)-induced increase of synde-
can-4 mRNA in fibroblasts. Human adult dermal fibroblasts were
treated with or without PDGF (100 ng per mL) in the absence or pres-
ence of varying doses of 5, 6 dichlorobenzimidazole 1-b-ribofuranoside
for 24 h. The total RNA was extracted with TRIZOL reagent. The levels
of syndecan-4 mRNA were determined with Access RT-PCR System
using two primers specifically against human syndecan-4 as described
in manufacturer’s protocols. Equal aliquots of extracted RNA were as-
sayed with primers specific for actin to confirm uniform sampling. The
data presented are representative of three separate experiments.
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volve the formation of clusters including both cell surface
GAG and integrins (Iida et al, 1996; Saoncella et al, 1999;
Woods et al, 2000). Therefore, to elucidate the role GAG on
3-D migration of human adult dermal fibroblasts beyond our
recent study on galactosaminoglycans (Clark et al, 2004),
we examined the role of HS by digesting fibroblasts with
heparinase I or III. Results demonstrated that HS is essential
for fibroblast transmigration from collagen gel into fibrin/FN
matrix. Many previous reports have demonstrated that he-
paran sulfate PG, especially as syndecan-4, can have pro-
found effects on cell adhesion and migration, cytoskeletal
organization and focal contact formation (Longley et al,
1999; Saoncella et al, 1999; Yoneda and Couchman, 2003).
In this study we demonstrated that syndecan-4 isolated
from human adult dermal fibroblasts bound to the HepII
domain of FN with slight but not statistically significant dif-
ferences by ANOVA among binding to FNIII12-14, FNIII12-
15, and FNIII12-V15. Syndecan-4 binding to FNIII12-V15
was only 20% greater than to FNIII12-15 while others have
found that heparin bound FNIII12-V15 almost 2-fold better
than FNIII12-15 (Mostafavi-Pour et al, 2001). The difference
in results could be attributable to heparin being more highly
sulfated than HS found on syndecan-4. Alternatively the
presence of syndecan-4 protein core might affect GAG in-
teractions with FN. Although Mostafavi-Pour et al found that
IIICS in context with the HepII bound heparin cooperatively,
no studies were done on the IIICS domain alone. In our
hands syndecan-4 had little or no affinity for IIICS when
presented as an isolated domain. Thus, from our syndecan-
4 binding data we hypothesized that the effects of HS on
cell migration may be related to the interaction of trans-
membrane syndecan-4, with the Hep II domain of FN.
Syndecan-4, but not the other syndecans, is localized in
highly organized FA in a range of cell types, is cooperative
with integrins in the assembly of FA and actin stress fibers,
and is involved in the control of cell morphology, cyto-
skeleton, and migration in cultured cells (Couchman and
Woods, 1999; Saoncella et al, 1999; Yoneda and Couch-
man, 2003). CHO-K cells expressing syndecan core protein
either with a partial or complete deletion of the cytoplasmic
domain or in conjunction with an antisense construct dem-
onstrated decreased spreading, FA formation and motility
(Longley et al, 1999). Contrawise, cells overexpressing full
length of syndecan-4 core protein exhibited a more flat-
tened fibroblastic morphology, with increased FA formation
and decreased cell motility (Longley et al, 1999). Thus, at
least in cell lines, syndecan-4 modulation can have pro-
found effects on cell adhesion and migration as well as focal
contact formation and cytoskeletal organization.
By using antisense oligodeoxynucleotides to specifically
suppress syndecan-4 expression, syndecan-4 was found
essential for human adult dermal fibroblast migration from
collagen gel into fibrin/FN matrix. Taken together our results
indicate that syndecan-4 PG is involved in 3-D migration of
human adult dermal fibroblasts through a provisional matrix
of FN and fibrin. In this process, syndecan-4 core protein is
Table I. Syndecan-4 antisense oligodeoxyribonucleotides do
not affect the expression of integrins a2, a5, and av
Mean Geometric mean
Negative control 149 135
Integrin a2 586 577
Integrin a2þSAS 587 576
Integrin a2þAS 575 564
Integrin a5 558 554
Integrin a5þSAS 564 559
Integrin a5þAS 566 560
Integrin av 567 559
Integrin avþSAS 590 582
Integrin avþAS 574 566
After treatment with or without antisense or missense oligodeoxyribonuc-
leotides for 48 h, cultured cells were detached with PBS containing 2 mM
EDTA and treated with integrin monoclonal antibodies for 60 min at 41C
as described in Materials and methods. Quantitative flow cytometry was
performed with a FACStar Plus cell sorter running LYSYS II software.
Results for each experimental sample were normalized to molecules of
equivalent soluble fluorophore (MESF) then the MESF value of the ap-
propriate antibody control was subtracted.
SAS, scrambled antisense oligonucleotides; AS, antisense oligonuc-
leotides; PBS, phosphate-buffered saline.
Figure6
Syndecan-2 antisense (AS) oligodeoxyribonucleotides fails to in-
hibit transmigration of fibroblasts. (A) Human adult dermal fibro-
blasts were treated with or without AS oligodeoxyribonucleotides or
scrambled antisense (SAS) oligodeoxyribonucleotides for 48 h in the
presence or absence of 100 ng per mL platelet-derived growth factor
(PDGF). At the conclusion of incubation cells were dissolved in affinity
bead binding buffer. After centrifugation, the supernatants were incu-
bated with affinity agarose beads to which syndecan-2 antibodies had
been conjugated. Bound syndecans were subjected to SDS-polyacryl-
amide gel electrophoresis, transferred to nitrocellulose, and probed
with goat antibodies specific for human syndecan-2. Gels were re-
probed with goat antibodies specific for human actin to confirm equal
loading. Syndecan-2 and actin were made visible by the chemilumi-
nescence method. The data presented are representative of three
separate determinations performed with separate cell lysates. (B) Cells
were treated with or without AS or SAS oligodeoxyribonucleotides for
48 h were subjected to 100 ng per mL PDGF in the transmigration
assay (see Materials and methods). All data presented are means  SD
from three determinations of one experiment and representative
of three experiments performed with cells from different antisense
treatments.
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probably cooperative with integrins in the assembly of FA
and actin stress fibers; while HS moieties of syndecan-4
interact with Hep II domain on FN. Both processes help
drive fibroblast migration in the FN containing matrix.
Although many studies have been focused on the role
of syndecan-4 in cell–ECM interaction, the regulation of
syndecan-4 expression in normal human dermal fibroblasts
has not been studied. It has been showed that syndecan-4
is induced by PR39, a proline-rich antimicrobial peptide,
which is present in early porcine wound fluid (Gallo et al,
1994). Furthermore, syndecan-4 was induced in the dermis
after incisional injury of murine or neonatal human skin
(Gallo et al, 1996). These results suggest that syndecan-4
upregulation might play a role in fibroblast migration from
the collagen-rich connective tissue into the wound provi-
sional matrix and wound healing.
During cutaneous wound repair, dermal fibroblasts are
exposed to a variety of growth factors, such as PDGF, and
many other cytokines. PDGF is a well-known growth factor
and chemotactic factor for fibroblasts in vitro and a critical
factor for wound healing in vivo (Heldin and Westermark,
1996). The upregulation of syndecan-4 by PDGF is consist-
ent with the observations that syndecan-4 is upregulated in
fibroblasts of the granulation tissue after skin injury (Gallo
et al, 1996). We previously found that PDGF strongly reg-
ulates the expression of ECM integrins (Gailit et al, 1996; Xu
and Clark, 1996), including those required for fibroblast
transmigration from collagen gels into fibrin/FN gels (Grei-
ling and Clark, 1997; Clark et al, 2003). Although many
growth factors and cytokines, including PDGF, were tested
for their ability to induce syndecan-1 and -4 in primary
mouse fibroblasts and fibroblast cell lines, none were re-
ported to do so (Gallo et al, 1994). Likewise PDGF failed to
increase syndecan-4 in human periodontal fibroblasts al-
though it up-regulated syndecan-1 (Worapamorn et al,
2001). Clearly a syndecan-4 response to PDGF is both
species and cell-type specific.
In these studies, PDGF is shown to upregulate the ex-
pression of syndecan-4 in human adult dermal fibroblasts at
both the translational and transcriptional level. These results
suggest a possible mechanism for syndecan-4 upregulation
in fibroblasts during human cutaneous injury. PDGF-
induced upregulation of syndecan-4 might be critical for
fibroblast migration and wound healing as syndecan-4 un-
dergoes rapid shedding in response to thrombin and epi-
dermal growth factor family members (Subramanian et al,
1997), a metalloproteinase-mediated phenomenon (Fit-
zgerald et al, 2000). Indeed, it has been demonstrated that
mice lacking syndecan-4 exhibit delayed wound repair and
impaired angiogenesis (Echtermeyer et al, 2001).
Materials and Methods
Materials Recombinant PDGF-BB was a kind gift from Charles
Hart at ZymoGenetics (Seattle, Washington). FN and thrombin
were generously provided by Gerard Marx (New York Blood Center,
New York, New York). FN was 99% pure and intact as determined
by SDS-polyacrylamide gel electrophoresis (PAGE). Bovine serum
albumin (BSA, fatty acid free, fraction V) was obtained from Miles
(Kankakee, Illinois). Dulbecco’s modified Eagle’s medium (DMEM)
was from Life Technology (Rockville, Maryland). Fetal bovine serum
(FBS) was from HyClone (Logan, Utah). Tissue culture flasks were
from Costar (Cambridge, Massachusetts). Penicillin, streptomycin,
and DRB were purchased from Sigma Chemicals (St Louis, Mis-
souri). Heparinase I, III (heparitinase I), and ovomucoid were pur-
chased from Seikagaku America (East Falmouth, Massachusetts).
Goat antibodies against human syndecan-2 (L-18), syndecan-4
(Goat H-19) and actin (C-11) were obtained from Santa Cruz Bio-
technology (Santa Cruz, California). Antibodies against human in-
tegrin a2 (clone P1E6), a5 (clone P1D6), av (clone P3G8) and
fluorescein-labeled antibody against mouse IgG Fc fragment were
acquired from Chemicon International (Temecula, California). Col-
lagen was from Cohesion Technologies (Palo Alto, California). Four
percent to 15% linear gradient Tris-HCl Ready Gel was from Bio-
Rad (Hercules, California). Access RT-PCR system, LDH assay kits
and MTT assay kits were from Promega Corporation (Madison,
Wisconsin). Immune pure immobilized avidin, sulfosuccin–
imidobiotin and Supersignal West Dura Extended Duration Subst-
rate were from Pierce (Rockford, Illinois).
Cell culture Primary cultures of human adult dermal fibroblasts (a
kind gift from Marcia Simon, Living Skin Bank, SUNY at Stony
Brook) were cultured in DMEM containing 42 mM sodium bicar-
bonate, 100 U per mL penicillin, 100 mg per mL streptomycin, and
10% FBS at 371C and 5% CO2/95% air in an humidified atmos-
phere. The cells were used between four and 15 passages.
Preparation of ﬂoating, contracted collagen gels Fibroblast
cultures at 80% confluence were harvested by treatment with
0.05% trypsin/0.02% EDTA. Trypsin was inactivated by addition of
soybean trypsin inhibitor in phosphate-buffered saline (PBS) con-
taining 2% BSA. The cells were washed twice with DMEM þ 2%
BSA and resuspended at a concentration of 1  106 cells per mL.
The fibroblasts were mixed with 2% BSA, neutralized collagen,
100 ng per mL PDGF-BB and DMEM so that the final concentration
of collagen was 1.8 mg per mL. Samples (0.6 mL) of cell mixture
were added to the wells of a 24-well tissue culture plate, which was
precoated with 2% BSA, and the collagen was allowed to polym-
erize at 371C. Each gel contained 6  104 cells. After 2 h incuba-
tion, gels were gently detached from the wells to allow contraction,
and 0.5 mL DMEMþ 2% BSA/100 ng per mL PDGF was added to
each well. The gels were incubated overnight at 371C in 5% CO2.
Preparation of assay wells with dried ﬁbrin ﬁbrils Fibrinogen
was mixed with concentrated DMEM and 0.5 U per mL thrombin
so that the final concentration of fibrinogen was 300 mg per mL and
DMEM and sodium bicarbonate were 1  . Samples of 450 mL
were added to the wells of a 24-well plate, and after a 2 h incu-
bation at 371C in 5% CO2, the polymerized gels were dried over-
night at room temperature under sterile conditions.
3-D transmigration Dried fibrin fibril-coated 24-well cell culture
plates were washed once with PBS and contracted collagen gels
were placed on the surface. Fibrinogen was mixed with DMEM and
1.0 U per mL thrombin to a final concentration of 300 mg per mL.
When needed, other supplements such as growth factors were
added to the mixture. The collagen gels were surrounded with the
fibrinogen solution so that the fibrin gel was level with the collagen
gel. After 24 h incubation at 371C, the number of migrated cells
was evaluated under a Nikon inverted phase microscope (Nikon,
Tokyo, Japan) by counting identifiable cell nuclei located outside of
the contracted collagen gel within the fibrin gel. Each condition
was run in triplicate and experiments were repeated at least three
times.
Addition of heparinase I or III to transmigration assays Some
contracted collagen gels were pretreated with heparinase I or III at
0.1 U per mL for 30 min prior to plating on a dried fibrin surface. In
addition, the appropriate enzyme, at the same concentration, was
added directly into the fibrinogen solution before addition of
thrombin.
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Syndecan-4 binding assay with FN fragments 35S-labeled
syndecan-4 was isolated from cultured human fibroblasts. Briefly,
cells were cultured in the presence of 50 mCi per mL of Na2
35SO4 in
DMEM containing 10% FCS for 48 h. After washing, cells were
dissolved in precipitation buffer (1% Triton X-100, 50 mM Tris-HCl,
50 mM NaCl, 0.75 mM CaCl2, 1 mM PMSF, 1 mM benzamide, 10
mg per mL of aprotinin and 10 mg per mL leupeptin). 35S-labeled
syndecan-4 was separated from the lysates by incubating with
syndecan-4 antibody conjugated to agarose beads at 41C for 3 h.
After washing, 35S-labeled syndecan-4 was dissociated from the
beads.
Functional human FN domains were cloned into pETCH vector,
which was constructed by modifying the pET vector from Strata-
gene (La Jolla, California). The inserts were cloned at the BamHI
and HindIII sites, and confirmed by DNA sequencing to rule out
possible synthesis errors during PCR. Protein expression was in-
duced in the BL1DE3LysS strain of Escherichia coli by the addition
of 0.5 mM isopropyl b-D-thiogalactoside and affinity-purified using
the Ni-NTA agarose (Qiagen, Valencia, California) according to the
manufacturer’s protocol. For binding assay, FN domains conjugat-
ed to agarose were incubated with 35S-labeled syndecan-4 (2000
CPM) at 41C for 2 h in precipitation buffer. After washing, the ra-
dioactivity binding to the FN-agarose beads were determined us-
ing a liquid scintillation counter.
Immunoblot analysis Samples of whole cell lysates or affinity-
purified syndecan-4 (see previous paragraph) were digested with
0.2 U per mL of heparinase I and III, dissolved in sample buffer, and
subjected to 4%–15% SDS-PAGE, using the Laemmli (1970) pro-
cedure. Separated proteins were transferred onto a nitrocellulose
membrane, blocked with 2% (wt/vol) BSA, and incubated with pri-
mary antibody specific for syndecans. After washing, the blots were
incubated with a second anti-rabbit/goat IgG antibody labeled with
peroxidase and developed by chemiluminescence method.
RNA extraction and RT-PCR Human fibroblasts were incubated
with or without 100 ng per mL of PDGF in the presence or absence
of varying concentration of DRB, a transcriptional inhibitor, for
24 h. Total cellular RNA was extracted with TRIZOL Reagent from
Invitrogen (Carlsbad, California). Manufacturer’s protocol was fol-
lowed. Briefly, fibroblasts grown in 35 mm culture dishes were
lysed directly in 1 mL of TRIZOL Reagent. The homogenized sam-
ples were incubated for 5 min at 201C. 0.2 mL of chloroform was
added and the samples were shaken for 15 s. After centrifugation,
the RNA in upper aqueous phase was precipitated with isopropyl
alcohol. The RNA pellet was washed with 75% ethanol and dried.
The relative level of syndecan-4 mRNA was analyzed using Access
RT-PCR System from Promega Corporation and manufacturer’s
protocol was followed. Actin was monitored as a control. Primers
for syndecan-4 at the 50-end (CTG GGA GCC AAG TCC CCA CCG)
and 30-end (GTC AGT ATT AGG TTG ACC TCA CC) were obtained
from Qiagen. Primers for actin at the 50- and 30-end were CCG GCA
TGT GCA AGG CCG GC and GCT CCA CGG GAG CCA CAC GC,
respectively (Qiagen).
Suppression via antisense oligodeoxyribonucleotides Phos-
phorothioate antisense to syndecan-4 (50-GGG GGC CAT GGC
ACC GCG G-30) and control missense oligodeoxyribonucleotides
with the same base composition, but in scrambled order (50-CGA
GCG GGG TCG CAC GGG C-30), were synthesized and purified to
cell culture-grade (Qiagen). Antisense and missense to syndecan 2
were 50-CCA CGC GCG CCG CATATC C-30 and 50-CAC GCC CGG
CGC ATC CCA TT-30, respectively (Qiagen). Before addition to
cells, oligodeoxyribonucleotides were mixed at a ratio of 1:3 (wt/
wt) with DOTAP, a cationic diacylglycerol in liposomal form that
serves as a delivery vehicle. Human fibroblasts were treated with
oligodeoxyribonucleotides (0.5 mg per mL) for at least 48 h prior
to the analysis of the expression of target molecule. Cells, in
which syndecan-4 was specifically suppressed by antisense
oligodeoxyribonucleotides, were then used for cell transmigration
and cell proliferation assays.
Integrin expression determined by ﬂow cytometry The effects
of syndecan-4 antisense oligodeoxyribonucleotides on integrin
expression were determined by flow cytometry. Briefly, after treat-
ment with or without antisense or missense oligodeoxyribonuc-
leotides for 48 h, the cultured cells were detached with PBS
containing 2 mM EDTA. The cells were then washed three times
with DMEMþ 0.2% BSA and resuspended in cold Hanksþ 0.2%
BSAþ 0.02% Azide (FCM) at 1.25  106 cells per mL. Followed by
incubation with 1/4 volume of blocking solution containing 10 mg
per mL human g-globulin and 0.2% sodium azide in HBSS at 41C
for 10 min, the cells were incubated with integrin monoclonal an-
tibodies for 60 min at 41C. After washing with FCM medium, the
cells were incubated with anti-mouse secondary antibody conju-
gated with FITC in FC medium (1:50 dilution) for 30 min at 41C. The
cells were washed with FC medium and then fixed with 2% para-
formaldehyde for 20 min on ice. After washing with PBS containing
0.2% sodium azide, the cell surface expression of integrin on cell
surface was analyzed by quantitative flow cytometry performed
with a FACStar Plus cell sorter (Becton Dickinson Immunocytome-
try System, San Jose, California) running LYSYS II software. The
results reported here are based upon calculated molecules of
equivalent soluble fluorophore (MESF) value for each experimental
sample minus the MESF value for the appropriate antibody control.
During this work Doris Greiling was supported by a Dermatology
Foundation Fellowship grant. In addition, funding was obtained from
NIH Grants AR 42987 and AG 101143 to R. A. F. C.
DOI: 10.1111/j.0022-202X.2005.23740.x
Manuscript received July 22, 2004; revised January 13, 2005; accept-
ed for publication February 1, 2005
Address correspondence to: Richard A. F. Clark, MD, Department of
Biomedical Engineering, School of Medicine and College of Engineer-
ing & Applied Science, SUNY at Stony Brook, Stony Brook, New York
11794-8165, USA. Email: Richard.Clark@sunysb.edu
References
Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, Lose EJ:
Biology of the syndecans: A family of transmembrane heparan sulfate
proteoglycans. Annu Rev Cell Biol 8:365–393, 1992
Borland G, Ross JA, Guy K: Forms and functions of CD44. Immunology 93:
139–148, 1998
Clark RAF: Wound repair: Overview and general considerations. In: Clark R (ed).
Molecular and Cellular Biology of Wound Repair. New York: Plenum
Press, 1996; p 3–50
Clark RAF, An JQ, Greiling D, Khan A, Schwarzbauer JE: Fibroblast migration on
fibronectin requires three distinct functional domains. J Invest Dermatol
121:695–705, 2003
Clark RAF, Lin F, An J, Greiling D, Couchman JR: Fibroblast invasive migration
into fibronectin/fibrin gels requires a previously uncharacterized dermatan
sulfate-CD44 proteoglycan. J Invest Dermatol 122:266–277, 2004
Couchman JR, Chen L, Woods A: Syndecans and cell adhesion. Int Rev Cytol
207:113–150, 2001
Couchman JR, Woods A: Syndecan-4 and integrins: Combinatorial signaling in
cell adhesion. J Cell Sci 112:3415–3420, 1999
Cukierman E, Pankov R, Yamada KM: Cell interactions with three-dimensional
matrices. Curr Opin Cell Biol 14:633–639, 2002
Danen EH, Yamada KM: Fibronectin, integrins, and growth control. J Cell Physiol
189:1–13, 2001
Echtermeyer F, Streit M, Wilcox-Adelman S, Saoncella S, Denhez F, Detmar M,
Goetinck P: Delayed wound repair and impaired angiogenesis in mice
lacking syndecan-4. J Clin Invest 107:9–R14, 2001
Fitzgerald ML, Wang Z, Park PW, Murphy G, Bernfield M: Shedding of syndecan-
1 and -4 ectodomains is regulated by multiple signaling pathways
and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol
148:811–824, 2000
912 LIN ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Gailit J, Xu J, Bueller H, Clark RAF: Platelet-derived growth factor and inflam-
matory cytokines have differential effects on the expression of integrins
a1b1 and a5b1 by human dermal fibroblasts in vitro. J Cell Physiol
169:281–289, 1996
Gallo R, Kim C, Kokenyesi R, Adzick NS, Bernfield M: Syndecans-1 and -4 are
induced during wound repair of neonatal but not fetal skin. J Invest De-
rmatol 107:676–683, 1996
Gallo RL, Ono M, Povsic T, Page C, Eriksson E, Klagsbrun M, Bernfield M:
Syndecans, cell surface heparan sulfate proteoglycans, are induced by a
proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci USA
91:11035–11039, 1994
Giancotti FG, Ruoslahti E: Integrin signaling. Science 285:1028–32, 1999
Greiling D, Clark RAF: Fibronectin provides a conduit for fibroblast transmigration
from collagenous stroma into fibrin clot provisional matrix. J Cell Sci
110:861–870, 1997
Gumbiner BM: Cell adhesion: The molecular basis of tissue architecture and
morphogenesis. Cell 84:345–358, 1996
Heldin C-H, Westermark B: Role of platelet-derived growth factor in vivo. In: Clark
RAF (ed). The Molecular and Cellular Biology of Wound Repair. New York:
Plenum Press, 1996; p. 249–273
Huttenlocher A, Ginsberg MH, Horwitz AF: Modulation of cell migration by in-
tegrin-mediated cytoskeletal linkages and ligand-binding affinity. J Cell
Biol 134:1551–1562, 1996
Iida J, Meijine AML, Knutson JR, Furcht LT, McCarthy JB: Cell surface chondroitin
sulfate proteoglycans in tumor cell adhesion, motility and invasion. Semin
Cancer Biology 7:155–162, 1996
Laemmli UK: Cleavage of structural proteins during the assembly of the head of
bacteriophage T-4. Nature 227:680–685, 1970
Longley RL, Woods A, Fleetwood A, Cowling GJ, Gallagher JT, Couchman JR:
Control of morphology, cytoskeleton and migration by syndecan-4. J Cell
Sci 112:3421–3431, 1999
McCarthy JB, Iida J, Furcht LT: Mechanisms of parenchymal cell migration into
wounds. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound
Repair. New York: Plenum Press, 1996; p 391–426
McClain SA, Simon M, Jones E, et al: Mesenchymal cell activation is the rate-
limiting step of granulation tissue induction. Am J Pathol 149:1257–1270,
1996
Mostafavi-Pour Z, Askari JA, Whittard JD, Humphries MJ: Identification of a novel
heparin-binding site in the alternatively spliced IIICS region of fibronectin:
Roles of integrins and proteoglycans in cell adhesion to fibronectin splice
variants. Matrix Biol 20:63–73, 2001
Oh ES, Couchman JR: Syndecans-2 and -4; close cousins, but not identical
twins. Mol Cells 17:181–187, 2004
Oh ES, Woods A, Couchman JR: Syndecan-4 proteoglycan regulates the dis-
tribution and activity of protein kinase C. J Biol Chem 272:8133–8136,
1997
Oh ES, Woods A, Lim ST, Theibert AW, Couchman JR: Syndecan-4 proteoglycan
cytoplasmic domain and phosphatidylinositol 4,5- bisphosphate coordi-
nately regulate protein kinase C activity. J Biol Chem 273:10624–10629,
1998
Saoncella S, Echtermeyer F, Denhez F, et al: Syndecan-4 signals cooperatively
with integrins in a Rho-dependent manner in the assembly of focal ad-
hesions and actin stress fibers. Proc Natl Acad Sci USA 96:2805–2810,
1999
Subramanian SV, Fitzgerald ML, Bernfield M: Regulated shedding of syndecan-1
and -4 ectodomains by thrombin and growth factor receptor activation.
J Biol Chem 272:14713–14720, 1997
Tumova S, Woods A, Couchman JR: Heparan sulfate chains from glypican and
syndecans bind the Hep II domain of fibronectin similarly despite minor
structural differences. J Biol Chem 275:9410–9417, 2000
Woods A, Longley RL, Tumova S, Couchman JR: Syndecan-4 binding to
the high affinity heparin-binding domain of fibronectin drives focal
adhesion formation in fibroblasts. Arch Biochem Biophys 374:66–72,
2000
Worapamorn W, Haase HR, Li H, Bartold PM: Growth factors and cytokines
modulate gene expression of cell-surface proteoglycans in human per-
iodontal ligament cells. J Cell Physiol 186:448–456, 2001
Xu J, Clark RAF: Extracellular matrix alters PDGF regulation of fibroblast inte-
grins. J Cell Biol 132:239–249, 1996
Yamada KM, Gailit J, Clark RAF: Integrins in wound repair. In: Clark R (ed). The
Molecular and Cellular Biology of Wound Repair. New York: Plenum Press,
1996; p 311–338
Yoneda A, Couchman JR: Regulation of cytoskeletal organization by syndecan
transmembrane proteoglycans. Matrix Biol 22:25–33, 2003
FIBROBLAST CLOT INVASION REQUIRES SYNDECAN-4 913124 : 5 MAY 2005
